Peripartum neuroactive steroid and γ-aminobutyric acid profiles in women at-risk for postpartum depression

Psychoneuroendocrinology

Volumn 70, Issue , 2016, Pages 98-107

  Deligiannidis, Kristina M ^a,b   Kroll Desrosiers, Aimee R ^a   Mo, Shunyan ^a   Nguyen, Hien P ^a   Svenson, Abby ^a   Jaitly, Nina ^a,c   Hall, Janet E ^c   Barton, Bruce A ^a   Rothschild, Anthony J ^a   Shaffer, Scott A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UMASS MEMORIAL MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Anxiety; Depression; Neuroactive steroid; Postpartum; Pregnancy; aminobutyric acid

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 3ALPHA,5BETA TETRAHYDROPROGESTERONE; 4 AMINOBUTYRIC ACID; 5ALPHA PREGNANE 3,20 DIONE; 5BETA DIHYDROPROGESTERONE; ELTANOLONE; NEUROACTIVE STEROID; PREGNENOLONE; PROGESTERONE; STEROID; UNCLASSIFIED DRUG; 20ALPHA DIHYDROPROGESTERONE; 4 AMINOBUTYRIC ACID A RECEPTOR; DEOXYCORTICOSTERONE;

ADULT; AMINO ACID BLOOD LEVEL; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; FEMALE; HAMILTON ANXIETY SCALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PERINATAL PERIOD; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PUERPERAL DEPRESSION; STATE TRAIT ANXIETY INVENTORY; STEROID BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; LONGITUDINAL STUDY; PHYSIOLOGY; POSTNATAL DEPRESSION; PREGNANCY; PSYCHOLOGY; RISK FACTOR;

20-ALPHA-DIHYDROPROGESTERONE; ADULT; CASE-CONTROL STUDIES; DEPRESSION, POSTPARTUM; DESOXYCORTICOSTERONE; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; LONGITUDINAL STUDIES; PERIPARTUM PERIOD; PREGNANCY; PREGNANOLONE; PROGESTERONE; RECEPTORS, GABA-A; RISK FACTORS; STEROIDS;

EID: 84968853411     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2016.05.010     Document Type: Article

References (69)

1. Altemus M., Fong J., Yang R., Damast S., Luine V., Ferguson D. Changes in cerebrospinal fluid neurochemistry during pregnancy. Biol. Psychiatry 2004, 56:386-392.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, DSM-5 2013, American Psychiatric Publishing, Washington, D.C. fifth edition.
3. Auchus R.J. Steroid assays and endocrinology: best practices for basic scientists. Endocrinology 2014, 155:2049-2051.
4. Barbaccia M.L., Roscetti G., Trabucchi M., Mostallino M.C., Concas A., Purdy R.H., Biggio G. Time-dependent changes in rat brain neuroactive steroid concentrations and GABAA receptor function after acute stress. Neuroendocrinology 1996, 63:166-172.
5. Barbaccia M.L., Roscetti G., Trabucchi M., Purdy R.H., Mostallino M.C., Concas A., Biggio G. The effects of inhibitors of GABAergic transmission and stress on brain and plasma allopregnanolone concentrations. Br. J. Pharmacol. 1997, 120:1582-1588.
6. Barbaccia M.L., Concas A., Serra M., Biggio G. Stress and neurosteroids in adult and aged rats. Exp. Gerontol. 1998, 33:697-712.
7. Berrettini W.H., Nurnberger J.I., Hare T., Gershon E.S., Post R.M. Plasma and CSF GABA in affective illness. Br. J. Psychiatry 1982, 141:483-487.
8. Bloch M., Schmidt P.J., Danaceau M., Murphy J., Nieman L., Rubinow D.R. Effects of gonadal steroids in women with a history of postpartum depression. Am. J. Psychiatry 2000, 157:924-930.
9. Bloch M., Rubinow D.R., Schmidt P.J., Lotsikas A., Chrousos G.P., Cizza G. Cortisol response to ovine corticotropin-releasing hormone in a model of pregnancy and parturition in euthymic women with and without a history of postpartum depression. J. Clin. Endocrinol. Metab. 2005, 90:695-699.
10. Bohlen P., Huot S., Palfreyman M.G. The relationship between GABA concentrations in brain and cerebrospinal fluid. Brain Res. 1979, 167:297-305.
11. Buckwalter J.G., Stanczyk F.Z., McCleary C.A., Bluestein B.W., Buckwalter D.K., Rankin K.P., Chang L., Goodwin T.M. Pregnancy, the postpartum, and steroid hormones: effects on cognition and mood. Psychoneuroendocrinology 1999, 24:69-84.
12. Buttner M.M., Mott S.L., Pearlstein T., Stuart S., Zlotnick C., O'Hara M.W. Examination of premenstrual symptoms as a risk factor for depression in postpartum women. Arch. Womens Ment. Health 2013, 16:219-225.
13. Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., Kupfer D.J. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989, 28:193-213.
14. Cox J.L., Holden J.M., Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh postnatal depression scale. Br. J. Psychiatry 1987, 150:782-786.
15. Crowley S.K., Girdler S.S. Neurosteroid, GABAergic and hypothalamic pituitary adrenal (HPA) axis regulation: what is the current state of knowledge in humans?. Psychopharmacology (Berl.) 2014, 231:3619-3634.
16. Cuthbert B.N., Insel T.R. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med. 2013, 11:126.
17. Deligiannidis K.M., Sikoglu E.M., Shaffer S.A., Frederick B., Svenson A.E., Kopoyan A., Kosma C.A., Rothschild A.J., Moore C.M. GABAergic neuroactive steroids and resting-state functional connectivity in postpartum depression: a preliminary study. J. Psychiatr. Res. 2013, 47:816-828.
18. Epperson C.N., Haga K., Mason G.F., Sellers E., Gueorguieva R., Zhang W., Weiss E., Rothman D.L., Krystal J.H. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Arch. Gen. Psychiatry 2002, 59:851-858.
19. Epperson C.N., Gueorguieva R., Czarkowski K.A., Stiklus S., Sellers E., Krystal J.H., Rothman D.L., Mason G.F. Preliminary evidence of reduced occipital GABA concentrations in puerperal women: a 1H-MRS study. Psychopharmacology (Berl.) 2006, 186:425-433.
20. Eser D., Romeo E., Baghai T.C., di Michele F., Schule C., Pasini A., Zwanzger P., Padberg F., Rupprecht R. Neuroactive steroids as modulators of depression and anxiety. Neuroscience 2006, 138:1041-1048.
21. Ferkany J.W., Smith L.A., Seifert W.E., Caprioli R.M., Enna S.J. Measurement of gamma-aminobutyric acid (GABA) in blood. Life Sci. 1978, 22:2121-2128.
22. Ferkany J.W., Butler I.J., Enna S.J. Effect of drugs on rat brain, cerebrospinal fluid and blood GABA content. J. Neurochem. 1979, 33:29-33.
23. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders-Patient Edition 2001, Biometrics Research Department New York State Psychiatric Institute, New York, NY.
24. Follesa P., Floris S., Tuligi G., Mostallino M.C., Concas A., Biggio G. Molecular and functional adaptation of the GABA(A) receptor complex during pregnancy and after delivery in the rat brain. Eur. J. Neurosci. 1998, 10:2905-2912.
25. Forty L., Jones L., Macgregor S., Caesar S., Cooper C., Hough A., Dean L., Dave S., Farmer A., McGuffin P., Brewster S., Craddock N., Jones I. Familiality of postpartum depression in unipolar disorder: results of a family study. Am. J. Psychiatry 2006, 163:1549-1553.
26. Gavin N.I., Gaynes B.N., Lohr K.N., Meltzer-Brody S., Gartlehner G., Swinson T. Perinatal depression: a systematic review of prevalence and incidence. Obstet. Gynecol. 2005, 106:1071-1083.
27. Gilbert Evans S.E., Ross L.E., Sellers E.M., Purdy R.H., Romach M.K. 3alpha-reduced neuroactive steroids and their precursors during pregnancy and the postpartum period. Gynecol. Endocrinol. 2005, 21:268-279.
28. Girdler S.S., Lindgren M., Porcu P., Rubinow D.R., Johnson J.L., Morrow A.L. A history of depression in women is associated with an altered GABAergic neuroactive steroid profile. Psychoneuroendocrinology 2012, 37:543-553.
29. Halbreich U., Petty F., Yonkers K., Kramer G.L., Rush A.J., Bibi K.W. Low plasma gamma-aminobutyric acid levels during the late luteal phase of women with premenstrual dysphoric disorder. Am. J. Psychiatry 1996, 153:718-720.
30. Hamilton M. The assessment of anxiety states by rating. Br. J. Med. Psychol. 1959, 32:50-55.
31. Herman J.P., Cullinan W.E. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci. 1997, 20:78-84.
32. Hill M., Parizek A., Bicikova M., Havlikova H., Klak J., Fait T., Cibula D., Hampl R., Cegan A., Sulcova J., Starka L. Neuroactive steroids, their precursors, and polar conjugates during parturition and postpartum in maternal and umbilical blood: 1. Identification and simultaneous determination of pregnanolone isomers. J. Steroid Biochem. Mol. Biol. 2000, 75:237-244.
33. Hill M., Parizek A., Klak J., Hampl R., Sulcova J., Havlikova H., Lapcik O., Bicikova M., Fait T., Kancheva R., Cibula D., Pouzar V., Meloun M., Starka L. Neuroactive steroids: their precursors and polar conjugates during parturition and postpartum in maternal and umbilical blood: 3. 3 Beta-hydroxy-5-ene steroids. J. Steroid Biochem. Mol. Biol. 2002, 82:241-250.
34. Hill M., Cibula D., Havlikova H., Kancheva L., Fait T., Kancheva R., Parizek A., Starka L. Circulating levels of pregnanolone isomers during the third trimester of human pregnancy. J. Steroid Biochem. Mol. Biol. 2007, 105:166-175.
35. Loscher W., Frey H.H. Transport of GABA at the blood-CSF interface. J. Neurochem. 1982, 38:1072-1079.
36. Loscher W., Rating D., Siemes H. GABA in cerebrospinal fluid of children with febrile convulsions. Epilepsia 1981, 22:697-702.
37. Loscher W. GABA in plasma and cerebrospinal fluid of different species. Effects of gamma-acetylenic GABA, gamma-vinyl GABA and sodium valproate. J. Neurochem. 1979, 32:1587-1591.
38. Lydsdottir L.B., Howard L.M., Olafsdottir H., Thome M., Tyrfingsson P., Sigurdsson J.F. The mental health characteristics of pregnant women with depressive symptoms identified by the Edinburgh postnatal depression scale. J. Clin. Psychiatry 2014, 75:393-398.
39. Magnaghi V., Parducz A., Frasca A., Ballabio M., Procacci P., Racagni G., Bonanno G., Fumagalli F. GABA synthesis in Schwann cells is induced by the neuroactive steroid allopregnanolone. J. Neurochem. 2010, 112:980-990.
40. Maguire J., Mody I. GABA(A)R plasticity during pregnancy: relevance to postpartum depression. Neuron 2008, 59:207-213.
41. Maguire J., Mody I. Steroid hormone fluctuations and GABA(A)R plasticity. Psychoneuroendocrinology 2009, 34(Suppl. 1):S84-90.
42. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 1986, 232:1004-1007.
43. Makara G.B., Stark E. Effects of gamma-aminobutyric acid (GABA) and GABA antagonist drugs on ACTH release. Neuroendocrinology 1974, 16:178-190.
44. Martinez P.E., Rubinow D.R., Nieman L.K., Koziol D.E., Morrow A.L., Schiller C.E., Cintron D., Thompson K.D., Khine K.K., Schmidt P.J. 5alpha-Reductase inhibition prevents the luteal phase increase in plasma allopregnanolone levels and mitigates symptoms in women with premenstrual dysphoric disorder. Neuropsychopharmacology 2016, 41:1093-1102.
45. Meijer J.L., Beijers C., van Pampus M.G., Verbeek T., Stolk R.P., Milgrom J., Bockting C.L., Burger H. Predictive accuracy of Edinburgh postnatal depression scale assessment during pregnancy for the risk of developing postpartum depressive symptoms: a prospective cohort study. BJOG: Int. J. Obstet. Gynaecol. 2014, 121:1604-1610.
46. Meltzer-Brody S., Boschloo L., Jones I., Sullivan P.F., Penninx B.W. The EPDS-Lifetime: assessment of lifetime prevalence and risk factors for perinatal depression in a large cohort of depressed women. Arch. Womens Ment. Health 2013, 16:465-473.
47. Milgrom J., Gemmill A.W., Bilszta J.L., Hayes B., Barnett B., Brooks J., Ericksen J., Ellwood D., Buist A. Antenatal risk factors for postnatal depression: a large prospective study. J. Affect. Disord. 2008, 108:147-157.
48. Mostallino M.C., Sanna E., Concas A., Biggio G., Follesa P. Plasticity and function of extrasynaptic GABA(A) receptors during pregnancy and after delivery. Psychoneuroendocrinology 2009, 34(Suppl. 1):S74-83.
49. Nappi R.E., Petraglia F., Luisi S., Polatti F., Farina C., Genazzani A.R. Serum allopregnanolone in women with postpartum blues. Obstet. Gynecol. 2001, 97:77-80.
50. Parizek A., Hill M., Kancheva R., Havlikova H., Kancheva L., Cindr J., Paskova A., Pouzar V., Cerny I., Drbohlav P., Hajek Z., Starka L. Neuroactive pregnanolone isomers during pregnancy. J. Clin. Endocrinol. Metab. 2005, 90:395-403.
51. Paul S.M., Purdy R.H. Neuroactive steroids. FASEB J. 1992, 6:2311-2322.
52. Pearson Murphy B.E., Steinberg S.I., Hu F.Y., Allison C.M. Neuroactive ring A-reduced metabolites of progesterone in human plasma during pregnancy: elevated levels of 5 alpha-dihydroprogesterone in depressed patients during the latter half of pregnancy. J. Clin. Endocrinol. Metab. 2001, 86:5981-5987.
53. Petty F., Kramer G., Feldman M. Is plasma GABA of peripheral origin?. Biol. Psychiatry 1987, 22:725-732.
54. Petty F. Plasma concentrations of gamma-aminobutyric acid (GABA) and mood disorders: a blood test for manic depressive disease?. Clin. Chem. 1994, 40:296-302.
55. Rothman K.J. No adjustments are needed for multiple comparisons. Epidemiology 1990, 1:43-46.
56. Sanacora G., Mason G.F., Rothman D.L., Behar K.L., Hyder F., Petroff O.A., Berman R.M., Charney D.S., Krystal J.H. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry 1999, 56:1043-1047.
57. Schiller C.E., Meltzer-Brody S., Rubinow D.R. The role of reproductive hormones in postpartum depression. CNS Spectr. 2015, 20:48-59.
58. Schmidt D., Loscher W. Plasma and cerebrospinal fluid gamma-aminobutyric acid in neurological disorders. J. Neurol. Neurosurg. Psychiatry 1982, 45:931-935.
59. Shear M.K., Vander Bilt J., Rucci P., Endicott J., Lydiard B., Otto M.W., Pollack M.H., Chandler L., Williams J., Ali A., Frank D.M. Reliability and validity of a structured interview guide for the Hamilton anxiety rating scale (SIGH-A). Depress. Anxiety 2001, 13:166-178.
60. Sheehan D.V. The Anxiety Disease 1983, Charles Scribner & Sons, New York.
61. Skrundz M., Bolten M., Nast I., Hellhammer D.H., Meinlschmidt G. Plasma oxytocin concentration during pregnancy is associated with development of postpartum depression. Neuropsychopharmacology 2011, 36:1886-1893.
62. Smith S.S., Gong Q.H., Hsu F.C., Markowitz R.S., ffrench-Mullen J.M., Li X. GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 1998, 392:926-930.
63. Smolen A., Smolen T.N., Han P.C. Alterations in regional brain GABA concentration and turnover during pregnancy. Pharmacol. Biochem. Behav. 1993, 44:63-69.
64. Spielberger C.D., Gorsuch R.L., Lushene R., Vagg P.R., Jacobs G.A. State Trait Anxiety Inventory 1970, Mind Garden Inc.
65. Taylor A., Atkins R., Kumar R., Adams D., Glover V. A new Mother-to-Infant Bonding Scale: links with early maternal mood. Arch. Womens Ment. Health 2005, 8:45-51.
66. Uhlhaas S., Lange H., Wappenschmidt J., Olek K. Free and conjugated CSF and plasma GABA in Huntington's chorea. Acta Neurol. Scand. 1986, 74:261-265.
67. Williams J.B. A structured interview guide for the hamilton depression rating scale. Arch. Gen. Psychiatry 1988, 45:742-747.
68. Wisner K.L., Perel J.M., Peindl K.S., Hanusa B.H., Findling R.L., Rapport D. Prevention of recurrent postpartum depression: a randomized clinical trial. J. Clin. Psychiatry 2001, 62:82-86.
69. Zhao C., Gammie S.C. Glutamate, GABA, and glutamine are synchronously upregulated in the mouse lateral septum during the postpartum period. Brain Res. 2014, 1591:53-62.